Progesterone treatment to prevent preterm birth

Drugs

Volumn 64, Issue 21, 2004, Pages 2463-2474

  Meis, Paul J ^a   Aleman, Alicia ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; HYDROXYPROGESTERONE CAPROATE; MEDROXYPROGESTERONE; PROGESTERONE; RITODRINE;

CHEMOPROPHYLAXIS; CLINICAL TRIAL; DRUG EFFICACY; DRUG IMPLANTATION; DRUG INDICATION; HIGH RISK PREGNANCY; HORMONAL THERAPY; HUMAN; PATHOPHYSIOLOGY; PREMATURE LABOR; REVIEW; SYSTEMATIC REVIEW; TOCOLYSIS;

FEMALE; HUMANS; PREGNANCY; PREMATURE BIRTH; PROGESTERONE; RANDOMIZED CONTROLLED TRIALS; TOCOLYTIC AGENTS;

EID: 8144225089     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200464210-00007     Document Type: Review

References (43)

1. da Fonseca EB, Bittar RE, Carvalho MHB, et al. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003; 188: 419-24
2. Meis PJ, Klebanoff M, Thorn E, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348: 2379-85
3. Paneth NS. The problem of low birth weight. Future Child 1995; 5: 19-34
4. Mattison DR, Damus K, Fiore E, et al. Preterm delivery: a public health perspective. Paediatr Perinat Epidemiol 2001; 15 Suppl. 2: 7-16
5. Gyetvai D, Hannah ME, Hodnett ED, et al. Tocolytics for preterm labor: a systematic review. Obstet Gynecol 1999; 94: 869-77
6. Harger JH. Cerclage and cervical insufficiency: and evidence-based analysis. Obstet Gynecol 2002; 100: 1313-27
7. Carey JC, Klebanoff MA, Hauth JC, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic vacterial vaginosis. N Engl J Med 2000; 342: 534-40
8. Klebanoff MA, Carey JC, Hauth JC, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asyptomatic Trichomonas Vaginalis infection. N Engl J Med 2001; 345: 487-93
9. Creasy RK. Preterm birth prevention: where are we? Am J Obstet Gynecol 1993; 168: 1223-30
10. Rebar RW, Cedars MI. Hypergonadotropic forms of amenorrhea in young women. Endocrinol Metab Clin North Am 1992 Mar; 21 (1): 173-91
11. Stites SP, Siiteri PK. Steroids as immunosppressants in pregnancy. Immunol Rev 1983; 75: 117-38
12. Siiteri PK. Seron-Ferre M. Some new thoughts on the feto-placental unit and parturition in primates. In: Novy JM, Reskko AJ, editors. Fetal endocrinology. New York: Academic Press, 1981: 1-34
13. Garfield RE, Dannan MS, Daniel EE. Gap junction formation in myometrium: control by estrogens, progesterone, and prostaglandins. Am J Physiol 1980; 238: C81-9
14. Challis JR. Sharp increase in free circulating oestrogens immediately before parturition in sheep. Nature 1971; 229: 208
15. Csapo AI. Progesterone 'block'. Am J Anat 1956; 98: 273-91
16. Cousins LM, Hobel CJ, Chang RJ, et al. Serum progesterone and estradiol-17β levels in premature and term labor. Am J Obstet Gynecol 1977; 127: 612-5
17. Johnson JWC, Lee PA, Zachary AS, et al. High-risk prematurity-progestin treatment and steroid studies. Obstet Gynecol 1979; 54: 412-8
18. Mitchell B, Cruickshank B, McLain D, et al. Local modulation of progesterone production in human fetal membranes. J Clin Endocrinol Metab 1982; 55: 1237-9
19. Romero R, Scoccia B, Mazor M, et al. Evidence for a local change in the progesterone/estrogen ratio in human parurition at term. Am J Obstet Gynecol 1988; 159: 657-60
20. Mazor M, Wiznitzer A, Levy J, et al. The relationship between estrogen/progesterone ratio and term human parturition. Isr J Med Sci 1993; 29: 97-9
21. Darne J. McGarrigle HHG, Lachelin GCL. Saliva oestriol, oestradiol, oestrone and progesterone levels in pregnancy: spontaneous labor at term is preceded by a prise in the saliva oestriol: progesterone ratio. Br J Obstet Gynaecol 1987; 94: 227-35
22. Jackson GM, McGregor JA, Lachelin GCL, et al. Salivary estriol rise predicts preterm labor. Am J Obstet Gynecol 1995; 172: 406
23. Buster JE, Meis PJ, Hobel CJ, et al. Subhourly variability of circulating third trimester maternal steroid concentrations as a source of sampling error. J Clin Endocrinol Metab 1978; 46: 907-10
24. Frydman R, LeLaidier C, Baton C, et al. Labor induction in women at term with mifepristone (RU 486): a double-blind, randomized, placebo-controlled study. Obstet Gynecol 1992; 80: 972-5
25. LeLaidier C, Baton C, Beniifla JL, et al. Mefipristone for labour induction after previous caesarean section. Br J Obstet Gynecol 1994; 101: 501-3
26. Chwalisz K, Fahrenholz F, Hackenbery M, et al. The progesterone antagonist onapristone increases the effectiveness of oxytocin to produce delivery without changing the myometrial oxutocin receptor concentrations. Am J Obstet Gynecol 1991; 165: 1760-70
27. Swyer GIM, Daley D. Progesterone implantation in habitual abortion. BMJ 1953 May 16; 1 (4819): 1073-7
28. Goldzieher J. Double-blind trial of a progestin in habitual abortion. JAMA 1964; 188: 651-4
29. Hobel CJ, Ross MG, Bemis RL, et al. The West Los Angeles Preterm Birth Prevention Project. I: program impact on high-risk women. Am J Obstet Gynecol 1994; 170: 54-62
30. LeVine L. Habitual abortion: a controlled clinical study of pregestational therapy. World J Surg 1964; 72: 3036
31. Papiernik E. Double bund study of an agent to prevent pre-term delivery among women at increased risk [in French]. Edition Schering 1970; Serie IV, fiche 3: 65-8
32. Johnson JWC, Austin KL, Jones GS, et al. Efficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of premature labor. N Engl J Med 1975; 292: 675-80
33. Yemini M, Borenstein R, Dreazen E, et al. Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol 1985; 151: 574-7
34. Suvonnakote T. Prevention of pre-term labour with progesterone. J Med Assoc Thailand 1986; 69: 538-42
35. Hartikainen-Sorri AL, Kauppila A, Tuimala R. Inefficacy of 17 alpha hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy. Obstet Gynecol 1980; 56: 692-5
36. Hauth JC, Gilstrap LC, Brekken AL, et al. The effect of 17 alpha-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population. Am J Obstet Gynecol 1983; 146: 187-19
37. Goldstein P, Berner J, Rosen S, et al. A meta-analysis of randomized control trials of progestational agents in pregnancy. Br J Obstet Gynecol 1989; 96: 265-74
38. Keirse MJNC. Progesterone administration in pregnancy may prevent pre-term delivery. Br J Obstet Gynecol 1990; 97: 149-54
39. Fuchs F, Stademann G. Treatment of threatened premature labor with large doses of progesterone. Am J Obstet Gynecol 1960; 79: 172-6
40. Kaupilla A, Hartikainen-Sorri A-L, Olli J, et al. Suppression of threatened premature labor by administration of cortisol and 17 alpha-hydroxyprogesterone caporate: a comparison with ritodrine. Am J Obstet Gynecol 1980; 138: 404-8
41. Erny R, Pigne C, Prouvost M, et al. The effects of oral administration of progesterone for premature labor. Am J Obstet Gynecol 1986; 154: 525-9
42. Noblot G, Audra P, Dargent D, et al. The use of micronized progesterone in the treatment of menace of preterm delivery. Eur J Obstet Gynecol Reprod Biol 1991; 40: 203-9
43. Brenner WE, Hendricks CH. Effect of medroxyprogesterone acetate upon the duration and characteristics of human gestation and labor. Am J Obstet Gynecol 1962; 83: 1094-8